In this way, considering that IL-10 plays a key role in modulating the immune response and that Chagas disease is characterized by a sustained inflammatory response that can cause cardiac dysfunction, development of new drugs that can induce the production of this cytokine in infected patients could have benefits such as preventing progression towards symptomatic forms or even contributing to reversing existing pathology [47]. This evidence concerns the gene IL10 and Chagas disease.